✦ LIBER ✦

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

✍ Scribed by Kausik Das; Kshaunish Das; Partha S. Mukherjee; Alip Ghosh; Sumantra Ghosh; Asit R. Mridha; Tapan Dhibar; Bhaskar Bhattacharya; Dilip Bhattacharya; Byomkesh Manna; Gopal K. Dhali; Amal Santra; Abhijit Chowdhury

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 230 KB
Volume: 51
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.23567

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonalcoholic fatty liver in a developing

Nonalcoholic fatty liver in a developing country is responsible for significant liver disease

✍ Ajay Duseja; Balkrishan Sharma; Amit Kumar; Shweta Kapil; Ashim Das; Radha K. Dh 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 1 views

We read with great interest the article by Cavazza et al., 1 who demonstrated that an advanced histological stage was the only risk factor associated with the development of hepatocellular carcinoma (HCC) in patients with primary biliary cirrhosis (PBC) from two European centers. Similar results wer

“Nonalcoholic fatty liver disease” in a

“Nonalcoholic fatty liver disease” in a developing country: A different perspective

✍ Sujoy Maitra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 1 views

I read with great interest the article by Das et al. 1 Although presence of nonalcoholic fatty liver (NAFL) in nonobese individuals is a fairly common observation in India, this is the first such scientific documentation for the same. However, I would like to make a few points in this regard. First

Role of leisure-time physical activity i

Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study

✍ Shira Zelber-Sagi; Dorit Nitzan-Kaluski; Rebecca Goldsmith; Muriel Webb; Izabel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

In vivo assessment of liver cell apoptos

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

✍ Anna Wieckowska; Nizar N. Zein; Lisa M. Yerian; A. Rocio Lopez; Arthur J. McCull 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 2 views

In patients with nonalcoholic fatty liver disease (NAFLD), a liver biopsy remains the only reliable way to differentiate simple steatosis from nonalcoholic steatohepatitis (NASH). Noninvasive methods are urgently needed. Increasing evidence suggests hepatocyte apoptosis is a key mediator of liver in

Serum M30 levels: A potential biomarker

Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

✍ Yusuf Yilmaz; Engin Ulukaya; Enver Dolar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

We congratulate Fracanzani and colleagues 1 on their insightful article identifying factors associated with severe liver disease in patients with nonalcoholic fatty liver disease (NAFLD) and normal aminotransferase levels. First, the authors have convincingly demonstrated that normal alanine aminotr

Risk of severe liver disease in nonalcoh

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

✍ Anna Ludovica Fracanzani; Luca Valenti; Elisabetta Bugianesi; Marco Andreoletti; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

It is uncertain whether patients with nonalcoholic fatty liver disease (NAFLD) and normal alanine aminotransferase (ALT) have a milder disease and should undergo liver biopsy. We reviewed the histological data of 458 Italian patients with NAFLD in whom liver biopsy was indicated by altered liver enz